| Psoriasis |
1 |
1 |
| Psoriatic Arthritis |
0 |
0.8 |
| Nail Psoriasis |
0 |
0.72 |
| Nail |
0 |
0.64 |
| Scan |
0 |
0.38 |
| Coronary Artery Disease (CAD) |
0 |
0.27 |
| Arthritis |
0 |
0.26 |
| Biologic Therapy |
0 |
0.19 |
| Cardiovascular disease |
0 |
0.13 |
| Cardiovascular Risk Management |
0 |
0.13 |
| Dermatoses |
0 |
0.13 |
| Food and Drug Administration (FDA) |
0 |
0.13 |
| Heart |
0 |
0.13 |
| Impairment |
0 |
0.13 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.13 |
| Pain |
0 |
0.13 |
| Pituitary Gland |
0 |
0.13 |
| Quality of Life |
0 |
0.13 |
| Scalp |
0 |
0.13 |
| Severity Index |
0 |
0.13 |
| Steroids |
0 |
0.13 |
| Topical Therapy |
0 |
0.13 |
| Pain Management |
0 |
0.1 |
| HIV Infection |
0 |
0.09 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.06 |
| Cerebrovascular Accident |
0 |
0.06 |